Stereotactic body radiotherapy for primary management of early-stage, low- to intermediate-risk prostate cancer: report of the American Society for Therapeutic Radiology and Oncology Emerging Technology Committee.
Buyyounouski
Mark K
MK
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. mark.buyyounouski@fccc.edu
Price
Robert A
RA
Harris
Eleanor E R
EE
Miller
Robert
R
Tomé
Wolfgang
W
Schefter
Tracey
T
Parsai
E Ishmael
EI
Konski
Andre A
AA
Wallner
Paul E
PE